Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurens A van Kleef

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Gastroenterology|September 8, 2024
ReplyLaurens A Van Kleef, Willem Pieter Brouwer
United European Gastroenterology Journal|September 12, 2022
Can we predict the future of patients with liver cirrhosis using volumetrics?Marten A Lantinga, Laurens A van Kleef
Hepatology (Baltimore, Md.)|September 18, 2025
Reply: Concerns regarding the diagnostic utility of non-invasive tests for clinically significant liver diseaseLaurens A van Kleef, Willem Pieter Brouwer
Hepatology Communications|May 20, 2022
Reply to: "Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD"Laurens A van Kleef, Robert J de Knegt
Hepatology (Baltimore, Md.)|September 16, 2022
Modifiable risk factors for fatty liver disease: Time to actLaurens A van Kleef, Robert J de Knegt
Hepatology (Baltimore, Md.)|May 3, 2022
The transition from NAFLD to MAFLD: One size still does not fit all-Time for a tailored approach?Laurens A van Kleef, Robert J de Knegt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2022
Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?Laurens A Van Kleef, Ibrahim Ayada, Robert J de Knegt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2022
Does NAFLD Prevalence Data Expire?Laurens A Van Kleef, Ibrahim Ayada, Robert J De Knegt
Journal of Hepatology|August 19, 2022
Reply to: "Liver stiffness, fatty liver disease and atrial fibrillation in the Rotterdam study: Some issues"Laurens A van Kleef, Maryam Kavousi, Robert J de Knegt
Cancers|October 27, 2022
Is Fasting Good When One Is at Risk of Liver Cancer?Iulia Minciuna, Laurens A van Kleef, Horia Stefanescu, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Gastroenterology|September 8, 2024
ReplyLaurens A Van Kleef, Willem Pieter Brouwer
United European Gastroenterology Journal|September 12, 2022
Can we predict the future of patients with liver cirrhosis using volumetrics?Marten A Lantinga, Laurens A van Kleef
Hepatology (Baltimore, Md.)|September 18, 2025
Reply: Concerns regarding the diagnostic utility of non-invasive tests for clinically significant liver diseaseLaurens A van Kleef, Willem Pieter Brouwer
Hepatology Communications|May 20, 2022
Reply to: "Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD"Laurens A van Kleef, Robert J de Knegt
Hepatology (Baltimore, Md.)|September 16, 2022
Modifiable risk factors for fatty liver disease: Time to actLaurens A van Kleef, Robert J de Knegt
Hepatology (Baltimore, Md.)|May 3, 2022
The transition from NAFLD to MAFLD: One size still does not fit all-Time for a tailored approach?Laurens A van Kleef, Robert J de Knegt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2022
Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?Laurens A Van Kleef, Ibrahim Ayada, Robert J de Knegt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2022
Does NAFLD Prevalence Data Expire?Laurens A Van Kleef, Ibrahim Ayada, Robert J De Knegt
Journal of Hepatology|August 19, 2022
Reply to: "Liver stiffness, fatty liver disease and atrial fibrillation in the Rotterdam study: Some issues"Laurens A van Kleef, Maryam Kavousi, Robert J de Knegt
Cancers|October 27, 2022
Is Fasting Good When One Is at Risk of Liver Cancer?Iulia Minciuna, Laurens A van Kleef, Horia Stefanescu, et al.
Pageof 6